Aethimizolum

Contraindications

Central nervous system arousal.

Pharmaceutical form

The substance is crystalline

Undesirable effects

Nausea, vomiting, dizziness, sleep disturbances, motor arousal.

Therapeutic indications

Respiratory depression, hypoventilation of the lungs, asthenodepressive conditions, polyarthritis, bronchial asthma, bronchospasm, asphyxia of newborns.

Pharmacotherapeutic group

  • Respiratory stimulants

Name of the medicinal product

Aethimizolum

Qualitative and quantitative composition

Methylamide Ethylimidazoledicarbonate

Dosage (Posology) and method of administration

In/in (slowly), in / m, n / a, to stimulate respiration-0.6-1 mg/kg of the patient's weight 1-2 times a day, with asphyxia of newborns-0.5 ml of 0.6% solution, with bronchospasm-2 ml of 1.5% solution 2 times a day. Inside, after meals-50-100 mg 3-4 times a day, the course — 20-30 days.